Peter T. Sawicki, Ulrike Didjurgeit, Ingrid Mühlhauser, Lutz Heinemann, Michael Berger
{"title":"伴有显性糖尿病肾病的盲型1型糖尿病患者的近正常血压和近正常血糖","authors":"Peter T. Sawicki, Ulrike Didjurgeit, Ingrid Mühlhauser, Lutz Heinemann, Michael Berger","doi":"10.1016/0891-6632(90)90019-2","DOIUrl":null,"url":null,"abstract":"<div><p>In patients with diabetic nephropathy, near-normalization of blood pressure (BP) and blood sugar may have a beneficial impact on changes in kidney function, but visually impaired patients may face difficulties when striving for optimal control of hypertension and hyperglycemia. In a prospective feasibility study, we followed a group of nine blind Type I (insulin-dependent) diabetic patients (mean age 30 ± 4 years) with overt diabetic nephropathy and uncontrolled hypertension. All patients received intensified insulin therapy after a structured diabetes treatment and teaching program, and adapted their antihypertensive drug treatment to self-monitored BP values. At recruitment, HbA<sub>1c</sub> values were 5.8 ± 0.6%, and remained stable at 6.3 ± 1.7% after a mean observation period of 27 months. BP pressure decreased from <span><math><mtext>150 ± </mtext><mtext>14</mtext><mtext>99</mtext><mtext> ± 14 </mtext><mtext>mmHg to 130 ± </mtext><mtext>17</mtext><mtext>86</mtext><mtext> ± 10 mmHg</mtext></math></span> after 1 year, and to <span><math><mtext>140 ± </mtext><mtext>14</mtext><mtext>99</mtext><mtext> ± 9 </mtext><mtext>mmHg</mtext></math></span> at the last examination, (<em>p</em> < 0.05). Serum creatinine and creatinine clearance remained stable over the observation period at 165 ± 56 μmol/L and 0.8 ± 0.4 ml/s/1.72m<sup>2</sup> at recruitment, and 152 ± 47 μmol/L and 1.0 ± 0.5 ml/s/1.72m<sup>2</sup> at the final examination. Proteinuria decreased from 3.2 to 1.4 g/24 h (<em>p</em> < 0.05). No patient needed renal replacement therapy. In a reference group of hypertensive Type I diabetic patients with overt nephropathy who did not have the opportunity to participate in the hypertension treatment and teaching program, BP increased despite antihypertensive therapy from <span><math><mtext>143 ± </mtext><mtext>19</mtext><mtext>87</mtext><mtext> ± 10 </mtext><mtext>mmHg</mtext></math></span> to <span><math><mtext>160 ± </mtext><mtext>28</mtext><mtext>95</mtext><mtext> ± 13 </mtext><mtext>mmHg</mtext></math></span> (NS) while serum creatinine increased from 165 ± 32 to 410 ± 285 μmol/L (<em>p</em> < 0.01). Four patients needed renal replacement therapy. These results indicate that after appropriate training, blind Type I diabetic patients with overt nephropathy may be able to achieve and maintain long-term normotension, and near-normal glycosylated hemoglobin values, which may have beneficial effects on renal function.</p></div>","PeriodicalId":77636,"journal":{"name":"The Journal of diabetic complications","volume":"4 4","pages":"Pages 179-183"},"PeriodicalIF":0.0000,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0891-6632(90)90019-2","citationCount":"12","resultStr":"{\"title\":\"Near-normotension and near-normoglycemia in blind Type I diabetic patients with overt diabetic nephropathy\",\"authors\":\"Peter T. Sawicki, Ulrike Didjurgeit, Ingrid Mühlhauser, Lutz Heinemann, Michael Berger\",\"doi\":\"10.1016/0891-6632(90)90019-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>In patients with diabetic nephropathy, near-normalization of blood pressure (BP) and blood sugar may have a beneficial impact on changes in kidney function, but visually impaired patients may face difficulties when striving for optimal control of hypertension and hyperglycemia. In a prospective feasibility study, we followed a group of nine blind Type I (insulin-dependent) diabetic patients (mean age 30 ± 4 years) with overt diabetic nephropathy and uncontrolled hypertension. All patients received intensified insulin therapy after a structured diabetes treatment and teaching program, and adapted their antihypertensive drug treatment to self-monitored BP values. At recruitment, HbA<sub>1c</sub> values were 5.8 ± 0.6%, and remained stable at 6.3 ± 1.7% after a mean observation period of 27 months. BP pressure decreased from <span><math><mtext>150 ± </mtext><mtext>14</mtext><mtext>99</mtext><mtext> ± 14 </mtext><mtext>mmHg to 130 ± </mtext><mtext>17</mtext><mtext>86</mtext><mtext> ± 10 mmHg</mtext></math></span> after 1 year, and to <span><math><mtext>140 ± </mtext><mtext>14</mtext><mtext>99</mtext><mtext> ± 9 </mtext><mtext>mmHg</mtext></math></span> at the last examination, (<em>p</em> < 0.05). Serum creatinine and creatinine clearance remained stable over the observation period at 165 ± 56 μmol/L and 0.8 ± 0.4 ml/s/1.72m<sup>2</sup> at recruitment, and 152 ± 47 μmol/L and 1.0 ± 0.5 ml/s/1.72m<sup>2</sup> at the final examination. Proteinuria decreased from 3.2 to 1.4 g/24 h (<em>p</em> < 0.05). No patient needed renal replacement therapy. In a reference group of hypertensive Type I diabetic patients with overt nephropathy who did not have the opportunity to participate in the hypertension treatment and teaching program, BP increased despite antihypertensive therapy from <span><math><mtext>143 ± </mtext><mtext>19</mtext><mtext>87</mtext><mtext> ± 10 </mtext><mtext>mmHg</mtext></math></span> to <span><math><mtext>160 ± </mtext><mtext>28</mtext><mtext>95</mtext><mtext> ± 13 </mtext><mtext>mmHg</mtext></math></span> (NS) while serum creatinine increased from 165 ± 32 to 410 ± 285 μmol/L (<em>p</em> < 0.01). Four patients needed renal replacement therapy. These results indicate that after appropriate training, blind Type I diabetic patients with overt nephropathy may be able to achieve and maintain long-term normotension, and near-normal glycosylated hemoglobin values, which may have beneficial effects on renal function.</p></div>\",\"PeriodicalId\":77636,\"journal\":{\"name\":\"The Journal of diabetic complications\",\"volume\":\"4 4\",\"pages\":\"Pages 179-183\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0891-6632(90)90019-2\",\"citationCount\":\"12\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of diabetic complications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0891663290900192\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of diabetic complications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0891663290900192","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Near-normotension and near-normoglycemia in blind Type I diabetic patients with overt diabetic nephropathy
In patients with diabetic nephropathy, near-normalization of blood pressure (BP) and blood sugar may have a beneficial impact on changes in kidney function, but visually impaired patients may face difficulties when striving for optimal control of hypertension and hyperglycemia. In a prospective feasibility study, we followed a group of nine blind Type I (insulin-dependent) diabetic patients (mean age 30 ± 4 years) with overt diabetic nephropathy and uncontrolled hypertension. All patients received intensified insulin therapy after a structured diabetes treatment and teaching program, and adapted their antihypertensive drug treatment to self-monitored BP values. At recruitment, HbA1c values were 5.8 ± 0.6%, and remained stable at 6.3 ± 1.7% after a mean observation period of 27 months. BP pressure decreased from after 1 year, and to at the last examination, (p < 0.05). Serum creatinine and creatinine clearance remained stable over the observation period at 165 ± 56 μmol/L and 0.8 ± 0.4 ml/s/1.72m2 at recruitment, and 152 ± 47 μmol/L and 1.0 ± 0.5 ml/s/1.72m2 at the final examination. Proteinuria decreased from 3.2 to 1.4 g/24 h (p < 0.05). No patient needed renal replacement therapy. In a reference group of hypertensive Type I diabetic patients with overt nephropathy who did not have the opportunity to participate in the hypertension treatment and teaching program, BP increased despite antihypertensive therapy from to (NS) while serum creatinine increased from 165 ± 32 to 410 ± 285 μmol/L (p < 0.01). Four patients needed renal replacement therapy. These results indicate that after appropriate training, blind Type I diabetic patients with overt nephropathy may be able to achieve and maintain long-term normotension, and near-normal glycosylated hemoglobin values, which may have beneficial effects on renal function.